Quality Assurance · Proton Therapy · Education · Patient Safety
Penn Medicine and IBA Form Noventra Oncology Alliance
October 4, 2026 · News Release
Source: Imaging Technology News
Penn Medicine and Ion Beam Applications announced Noventra Oncology Alliance on September 28, 2026. The joint venture will offer services to healthcare organizations developing or expanding proton therapy and advanced radiation oncology programs.
Its planned work covers strategic and financial planning, clinical readiness, implementation and ongoing operations. The partners intend to combine Penn Medicine's clinical, research and education experience with IBA's technology and project-development expertise.
The announcement addresses the practical demands of establishing a treatment program, including workforce preparation, reimbursement, capital planning and operational performance. It is relevant to health systems evaluating new proton therapy services or strengthening existing ones.
The venture is a service and infrastructure initiative. Its formation does not itself demonstrate improved patient outcomes or comparative effectiveness of proton therapy.
